Jefferies Issues a Hold Rating on Medpace Holdings

By Ryan Adsit

In a report released today, David Windley from Jefferies reiterated a Hold rating on Medpace Holdings (NASDAQ: MEDP), with a price target of $35.50. The company’s shares opened today at $30.46.

According to, Windley is a top 100 analyst with an average return of 15.8% and a 74.8% success rate. Windley covers the Healthcare sector, focusing on stocks such as Quintiles Transnational, WellCare Health Plans, and PRA Health Sciences.

Medpace Holdings has an analyst consensus of Hold, with a price target consensus of $35.50.

Medpace Holdings’ market cap is currently $1.22B and has a P/E ratio of 84.20. The company has a book value ratio of 2.0268.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Medpace Holdings, Inc. engages in the research, development, and trade of medical device and pharmaceutical products. Its services include clinical operations, medical writing and reviewing, biometrics, pharmacovigilance, imaging core lab, clinical pharmacology, interactive voice response system, pharmacokinetics, pharmacodynamics, and cardiovascular core laboratory. The company was founded by August J. Troendle in July 1992 and is headquartered in Cincinnati, OH.